850
Views
5
CrossRef citations to date
0
Altmetric
Brief Report

RAS ubiquitylation modulates effector interactions

, &
Pages 180-185 | Received 17 Jul 2017, Accepted 18 Aug 2017, Published online: 29 Nov 2017

Figures & data

Table 1. Comparative binding affinity of wt KRAS and mUbRas with GAP and effector proteins.

Figure 1. Panel A: Fluorescence binding curve of KRAS (mGppCp) with GAPcat (Kd = 1.9 ± 0.2 μM) compared with Panel B: Fluorescence binding assay of mUbRAS (mGppCp) with GAPcat (Kd = 19.4± 1.4 μM). Panel C: Relative binding affinity of KRAS (mGppCp, black bars) and mUbRAS (mGppCp, blue bars) with effectors CRAF RBD, RALGDS, and PI3Kcγ. Monoubiquitylated KRAS (mGppCp) shows a 7 to 9-decrease in affinity to the CRAF RBD, RalGDS RBD, and PI3Kcγ. Statistical error was determined from 3–5 independent experiments. Panel D: In contrast, mUbRAS (GDP shows 45-fold higher affinity relative to wt KRAS (GDP). Statistical error was determined from 3–5 independent experiments.

Figure 1. Panel A: Fluorescence binding curve of KRAS (mGppCp) with GAPcat (Kd = 1.9 ± 0.2 μM) compared with Panel B: Fluorescence binding assay of mUbRAS (mGppCp) with GAPcat (Kd = 19.4± 1.4 μM). Panel C: Relative binding affinity of KRAS (mGppCp, black bars) and mUbRAS (mGppCp, blue bars) with effectors CRAF RBD, RALGDS, and PI3Kcγ. Monoubiquitylated KRAS (mGppCp) shows a 7 to 9-decrease in affinity to the CRAF RBD, RalGDS RBD, and PI3Kcγ. Statistical error was determined from 3–5 independent experiments. Panel D: In contrast, mUbRAS (GDP shows 45-fold higher affinity relative to wt KRAS (GDP). Statistical error was determined from 3–5 independent experiments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.